Nexel

Nexel

Nexel was incorporated in 2010 with proprietary stem cell technologies to support innovative research with high quality stem cell-derived products.

Using cutting-edge techniques, Nexel manufacture functional, pure populations of cardiomyocytes, hepatocytes and glutamatergic neurons derived from human induced pluripotent stem cells (hiPSCs) for efficient drug toxicity screening. 

Cambridge Bioscience is pleased to distribute Nexel products exclusively in the UK.